Cigna Group (CI) stock
CINYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3023% below fair value
$297.00+0.73 (+0.25%)
Close on Nov 13, 2026Market cap $78.48BP/E 13.1Yield 2.03%
Cigna operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cigna's operating income for the twelve months ending Sep 30, 2026 was $9.78B, up 8.3% year over year. For fiscal 2025 it was $9.20B, down 2.3% from the year before. The highest annual figure on record is $9.42B in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.20B | -2.3% |
| FY2024 | Dec 31, 2024 | $9.42B | +10.3% |
| FY2023 | Dec 31, 2023 | $8.54B | +1.0% |
| FY2022 | Dec 31, 2022 | $8.45B | +6.4% |
| FY2021 | Dec 31, 2021 | $7.94B | -2.6% |
| FY2020 | Dec 31, 2020 | $8.15B | +0.9% |
| FY2019 | Dec 31, 2019 | $8.08B | +94.2% |
| FY2018 | Dec 31, 2018 | $4.16B | +5.5% |
| FY2017 | Dec 31, 2017 | $3.94B | +27.7% |
| FY2016 | Dec 31, 2016 | $3.09B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.40B | -7.1% |
| Q2 FY2026 | Jun 30, 2026 | $2.68B | +16.0% |
| Q1 FY2026 | Mar 31, 2026 | $2.36B | +19.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.35B | +7.9% |
| Q3 FY2025 | Sep 30, 2025 | $2.58B | +0.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.31B | -4.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.97B | -12.6% |
| Q4 FY2024 | Dec 31, 2024 | $2.17B | +5.5% |
| Q3 FY2024 | Sep 30, 2024 | $2.58B | +15.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.41B | +8.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.26B | +12.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.06B | +17.8% |
| Q3 FY2023 | Sep 30, 2023 | $2.24B | +4.6% |
| Q2 FY2023 | Jun 30, 2023 | $2.22B | -6.3% |
| Q1 FY2023 | Mar 31, 2023 | $2.02B | -7.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.75B | +13.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.14B | -6.6% |
| Q2 FY2022 | Jun 30, 2022 | $2.37B | +10.4% |
| Q1 FY2022 | Mar 31, 2022 | $2.19B | +11.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.54B | +14.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.29B | +8.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.15B | -18.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.96B | -5.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.35B | -13.8% |
| Q3 FY2020 | Sep 30, 2020 | $2.11B | -0.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.64B | +22.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.06B | -7.6% |
| Q4 FY2019 | Dec 31, 2019 | $1.56B | +179.2% |
| Q3 FY2019 | Sep 30, 2019 | $2.12B | +87.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.16B | +86.3% |
| Q1 FY2019 | Mar 31, 2019 | $2.23B | +70.5% |
| Q4 FY2018 | Dec 31, 2018 | $559.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.13B | – |
| Q2 FY2018 | Jun 30, 2018 | $1.16B | – |
| Q1 FY2018 | Mar 31, 2018 | $1.31B | – |
See a number that looks wrong?